Godwin, C. D., Bates, O. M., Garling, E. E., Beddoe, M. E., Laszlo, G. S., & Walter, R. B. (2020). The Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Abrogates Bispecific Antibody-Mediated T-cell Cytotoxicity. Br J Haematol.

Godwin, Colin D., Olivia M. Bates, Eliotte E. Garling, Mary E. Beddoe, George S. Laszlo, and Roland B. Walter. "The Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Abrogates Bispecific Antibody-Mediated T-cell Cytotoxicity." Br J Haematol 2020.

Godwin, Colin D., et al. "The Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Abrogates Bispecific Antibody-Mediated T-cell Cytotoxicity." Br J Haematol 2020.